Early changes (increases) in MMP-1 concentrations post-CXCL12 injection may play a role in the attenuation of renal fibrosis with CXCL12 treatment, but our small sample size (n = 1) precludes us from making this conclusion. Here, CXCL12 is linked to renal fibrosis.